Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Accounting and Finance

Founder, Chief Executive Officer and President

Chief Financial Officer and Executive Vice President, Corporate Strategy

Ultragenyx sells portion of Crysvita royalties for $400 million

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences

Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update

Ultragenyx Pharmaceutical Q3 Net Loss Widens, Revenue Increases

Intern, Drug Substance Manufacturing - Downstream and Central Services

Ultragenyx is a company dedicated to leading the future of rare disease medicine. They are seeking an Intern for their Gene Therapy Manufacturing Facility in Bedford, MA, where the role involves supporting downstream manufacturing processes and adhering to quality and safety standards.

Intern, Drug Substance Manufacturing - Downstream and Central Services (Mon-Fri, 2pm-10:30pm)

Senior Manager - Manufacturing - Gene Therapy

Manufacturing Associate Level III

Specialist II, Global CMC Development, Business Operations / Clinical Operations

Sign up with Google

Sign in with Google